# Alliance A021501 (NCT02839343)

> Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02839343
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Pancreatic Adenocarcinoma; Borderline Resectable Adenocarcinoma of the Head of the Pancrease
- Interventions: radiation therapy; surgery; mFOLFIRINOX; FOLFOX
- Enrollment: 126
- Primary outcome: Overall Survival (OS) Rate

## Indexed commentary on Alliance A021501 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 18
- Podcasts: 2
- YouTube: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=alliance-a021501-nct02839343

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02839343", "email": "<work email>"}; the inbox owner confirms by the emailed link.